HUTCHISON CHINA/S (NASDAQ:HCM) was downgraded by equities research analysts at ValuEngine from a “buy” rating to a “hold” rating in a research note issued on Thursday, ValuEngine reports.

HCM has been the topic of several other research reports. Cantor Fitzgerald assumed coverage on shares of HUTCHISON CHINA/S in a report on Thursday, March 12th. They issued an “overweight” rating on the stock. BidaskClub raised shares of HUTCHISON CHINA/S from a “buy” rating to a “strong-buy” rating in a report on Thursday, June 25th. Finally, Zacks Investment Research downgraded shares of HUTCHISON CHINA/S from a “hold” rating to a “sell” rating in a report on Tuesday. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average price target of $26.50.

NASDAQ HCM opened at $28.53 on Thursday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 2.66 and a current ratio of 2.80. The firm has a market cap of $3.81 billion, a PE ratio of -35.66 and a beta of 1.15. HUTCHISON CHINA/S has a one year low of $14.74 and a one year high of $29.92. The firm’s fifty day moving average is $23.18 and its two-hundred day moving average is $23.15.

Hedge funds have recently modified their holdings of the stock. PNC Financial Services Group Inc. increased its position in HUTCHISON CHINA/S by 109.1% during the fourth quarter. PNC Financial Services Group Inc. now owns 1,677 shares of the company’s stock worth $43,000 after purchasing an additional 875 shares during the last quarter. Quadrant Capital Group LLC acquired a new position in HUTCHISON CHINA/S during the fourth quarter worth approximately $68,000. Shell Asset Management Co. increased its position in HUTCHISON CHINA/S by 91.4% during the first quarter. Shell Asset Management Co. now owns 9,007 shares of the company’s stock worth $161,000 after purchasing an additional 4,300 shares during the last quarter. APG Asset Management N.V. purchased a new stake in HUTCHISON CHINA/S during the first quarter worth approximately $198,000. Finally, Krane Funds Advisors LLC grew its stake in HUTCHISON CHINA/S by 31.3% during the first quarter. Krane Funds Advisors LLC now owns 11,440 shares of the company’s stock worth $204,000 after buying an additional 2,727 shares during the period. 30.90% of the stock is owned by hedge funds and other institutional investors.

About HUTCHISON CHINA/S

Hutchison China MediTech Limited, a commercial-stage biopharmaceutical company, engages in discovery, development, and commercialization of targeted therapeutics and immunotherapies for oncology and immunological diseases in the People's Republic of China and Hong Kong. The company operates through Innovation Platform and Commercial Platform segments.

Read More: How Do You Calculate Return on Investment (ROI)?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for HUTCHISON CHINA/S (NASDAQ:HCM)

Receive News & Ratings for HUTCHISON CHINA/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HUTCHISON CHINA/S and related companies with MarketBeat.com's FREE daily email newsletter.